HR
FBIO icon

Howe & Rusling’s Fortress Biotech FBIO Stock Holding History

Howe & Rusling’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1
Closed – – 866
2014
Q1 		$0 Buy
+1
New +$39 ﹤0.01% 866

Other funds holding FBIO

EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Howe & Rusling's FBIO Position: Q2 2014 in Review

Howe & Rusling sold out of Fortress Biotech (FBIO) in Q2 2014, closing a stake of 1 share.

Howe & Rusling first reported a position in FBIO in Q1 2014 and held it in 1 quarter. The position peaked at $0 in Q1 2014. 48 funds tracked by Wall St. Rank hold FBIO as of Q2 2014.

  • Howe & Rusling reported no remaining Fortress Biotech position as of Q2 2014 after selling out during the quarter.
  • Howe & Rusling sold 1 Fortress Biotech share in Q2 2014.
  • Howe & Rusling first reported a position in Fortress Biotech in Q1 2014 and held it in 1 quarter.
  • Howe & Rusling's Fortress Biotech position peaked at $0 in Q1 2014.
  • 48 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2014.

Based on Howe & Rusling's 13F filing for Q2 2014, filed 31 Jul 2014.